1-6 of 6
Hiroki Goto
Close
Sort by
Journal Articles

EZH1/2 Dual Inhibitor Valemetostat Tosylate (DS-3201b) Acts Differently from EZH2 Selective Inhibitor on Epigenetic Landscape to Exert Greater Anti-Tumor Effect Against Diffuse Large B-Cell Lymphoma

Toshihiro Banjo, Yasuhiro Hama, Emi Nosaka, Yoshimi Takata, Daisuke Honma, Mayumi Kitagawa, Yuka Yamamoto, Chisa Wada, Takanori Yoshida, Kyungtaek Lim, Atsushi Okamoto, Erina Sato, Yumiko Katayama, Kazumi Sato, Hiroki Goto, Yuki Abe
Journal: Blood
Blood (2021) 138 (Supplement 1): 2948.
https://doi.org/10.1182/blood-2021-146772
Published: 2021
Journal Articles

Anti-Tumor Effect of the EZH1/2 Dual Inhibitor Valemetostat Against Diffuse Large B-Cell Lymphoma Via Modulation of B-Cell Receptor Signaling and c-Myc Signaling Pathways

Yasuhiro Hama, PhD, Toshihiro Banjo, PhD, Daisuke Honma, PhD, Yoshimi Takata, Emi Nosaka, Machiko Shiroishi, Kenji Watanabe, Yuka Yamamoto, Tsuyoshi Hirata, Rika Nakano, Koichiro Inaki, PhD, Hiroki Goto, PhD, Yusuke Totoki, PhD, Miki Kataoka, Kyungtaek Lim, PhD, Chisa Wada, Eiji Kumazawa, PhD, Shinji Tsutsumi, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4642.
https://doi.org/10.1182/blood-2019-125436
Published: 2019
Journal Articles

High Burden of Clonal Hematopoiesis in First Responders Exposed to the World Trade Center Disaster

Sakshi Jasra, MD, Orsi Giricz, PhD, Rachel Zeig-Owens, M.P.H, David Goldfarb, M.P.H, Angelica Barreto-Galvez, Kith Pradhan, PhD, Jiahao Chen, PhD, Gaurav S Choudhary, PhD, Srinivas Aluri, Tushar D Bhagat, PhD, Aditi Shastri, MD, Victor Thiruthuvanathan, M.S, Hiroki Goto, MD PhD, Jeannine Gerhardt, PhD, Shanisha Gordon, Arul Veerappan, PhD, Syed Hissam Haider, MD, Matthias Bartenstein, MD, George Nwankwo, Ola Landgren, MD PhD, Michael Weiden, MD, Frederick Fletcher, Lee Greenberger, PhD, Benjamin L. Ebert, MD PhD, Ulrich G. Steidl, MD PhD, Britta Will, PhD, Anna Nolan, MD MS, David Prezant, MD, Advaitha Madireddy, PhD, Amit Verma, MBBS
Journal: Blood
Blood (2019) 134 (Supplement_1): 3720.
https://doi.org/10.1182/blood-2019-129276
Published: 2019
Journal Articles

Mechanism of Pax5 Down-Regulation and Its Function in Primary Effusion Lymphoma

Hiroki Goto, MD, PhD, Ryusho Kariya, PhD, Eriko Kudo, PhD, Seiji Okada, MD, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3791.
https://doi.org/10.1182/blood.V130.Suppl_1.3791.3791
Published: 2017
Journal Articles

Role of PU.1 Down-Regulation for the Development of Primary Effusion Lymphoma

Hiroki Goto, MD, PhD, Ryusho Kariya, PhD, Eriko Kudo, PhD, Yutaka Okuno, MD, PhD, Seiji Okada, MD, PhD
Journal: Blood
Blood (2016) 128 (22): 4091.
https://doi.org/10.1182/blood.V128.22.4091.4091
Published: 2016
Journal Articles

Evaluation Of Targeting CD47-SIRPĪ± Using Primary Effusion Lymphoma Xenograft Mouse Model

Hiroki Goto, MD, Eriko Kudo, Kouki Matsuda, Ryusho Kariya, Manabu Taura, PhD, Seiji Okada, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1827.
https://doi.org/10.1182/blood.V122.21.1827.1827
Published: 2013